Show simple item record

dc.contributor.authorLabaran, Lawalen
dc.contributor.authorBell, Joshuaen
dc.contributor.authorPuvanesarajah, Varunen
dc.contributor.authorJain, Nikhilen
dc.contributor.authorAryee, Jomar N.en
dc.contributor.authorRaad, Michealen
dc.contributor.authorJain, Amiten
dc.contributor.authorCarmouche, Jonathanen
dc.contributor.authorHassanzadeh, Hamiden
dc.date.accessioned2020-08-10T17:59:22Z
dc.date.available2020-08-10T17:59:22Z
dc.date.issued2020-06en
dc.identifier.issn2586-6583en
dc.identifier.urihttp://hdl.handle.net/10919/99633
dc.description.abstractObjective: Although spinal cord stimulators (SCS) continue to gain acceptance as a viable nonpharmacologic option for the treatment of chronic back pain, recent trends are not well established. The aim of this study was to evaluate recent overall demographic and regional trends in paddle lead SCS placement and to determine if differences in trends exist between private-payer and Medicare beneficiaries. Methods: A retrospective review of Medicare and private-payer insurance records from 2007-2014 was performed to identify patients who underwent a primary paddle lead SCS placement via a laminectomy (CPT-63655). Each study cohort was queried to determine the annual rate of SCS placements and demographic characteristics. Yearly SCS implantation rates within the study cohorts were adjusted per 100,000 beneficiaries. A chi-square analysis was used to compare changes in annual rates. Results: A total of 31,352 Medicare and 2,935 private-payer patients were identified from 2007 to 2014. Paddle lead SCS placements ranged from 5.9 to 17.5 (p<0.001), 1.9 to 5.9 (p<0.001), and 5.2 to 14.5 (p<0.001) placements per 100,000 Medicare, private-payer, and overall beneficiaries respectively from 2007 to 2014. SCS placements peaked in 2013 with 19.6, 7.1, and 16.8 placements per 100,000 Medicare, private-payer, and overall patients. Conclusion: There was an overall increase in the annual rate of SCS placements from 2007 to 2014. Paddle lead SCS placements peaked in 2013 for Medicare, private-payer, and overall beneficiaries. The highest incidence of implantation was in the Southern region of the United States and among females. Yearly adjusted rates of SCSs were higher among Medicare patients at all time points.en
dc.format.mimetypeapplication/pdfen
dc.language.isoenen
dc.rightsCreative Commons Attribution-NonCommercial 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/en
dc.subjectSpinal cord stimulationen
dc.subjectBack painen
dc.subjectDemographyen
dc.subjectMedicareen
dc.subjectLaminectomyen
dc.titleDemographic Trends in Paddle Lead Spinal Cord Stimulator Placement: Private Insurance and Medicare Beneficiariesen
dc.typeArticle - Refereeden
dc.contributor.departmentVirginia Tech Carilion School of Medicineen
dc.title.serialNeurospineen
dc.identifier.doihttps://doi.org/10.14245/ns.1938276.138en
dc.identifier.volume17en
dc.identifier.issue2en
dc.type.dcmitypeTexten
dc.type.dcmitypeStillImageen
dc.identifier.pmid32054146en
dc.identifier.eissn2586-6591en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution-NonCommercial 4.0 International
License: Creative Commons Attribution-NonCommercial 4.0 International